Serum MMP-9 and IL-1β levels in acute ischemic stroke and their association with initial neurological severity: a case-control study
References
- Feigin VL, Brainin M, Norrving B, Martins SO, Pandian J, Lindsay P, et al. World Stroke Organization: Global Stroke Fact Sheet 2025. Int J stroke Off J Int Stroke Soc. 2025 Feb;20(2):132–44.
- Majumder D. Ischemic Stroke: Pathophysiology and Evolving Treatment Approaches. Neurosci insights. 2024;19:26331055241292600.
- Yang Y, Zhu H, Xiong T, Li S. Inflammatory Biomarkers in Ischemic Stroke: Mechanisms, Clinical Applications, and Future Directions. Neurosurg Subspecialties [Internet]. 2025;1(4):188–96. Available from: https://www.xiahepublishing.com/3067-6150/NSSS-2025-00029
- Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011 Jul;17(7):796–808.
- Alsbrook DL, Di Napoli M, Bhatia K, Biller J, Andalib S, Hinduja A, et al. Neuroinflammation in Acute Ischemic and Hemorrhagic Stroke. Curr Neurol Neurosci Rep. 2023 Aug;23(8):407–31.
- Sun B, Zhang J, Li Z, Wang J, Zhao C, Xu X. Role of damage-associated molecular patterns in the pathogenesis and therapeutics of traumatic brain injury. Burn Trauma [Internet]. 2025 Jan 3;13:tkaf043. Available from: https://doi.org/10.1093/burnst/tkaf043
- Blase A, di Girasole CG, Benjamin L, Turowski P. Phased blood-brain barrier disruption in ischaemic stroke: implications for therapy? Fluids Barriers CNS. 2025 Aug;22(1):90.
- Sasannia S, Leigh R, Bastani PB, Shin HG, van Zijl P, Knutsson L, et al. Blood-brain barrier breakdown in brain ischemia: Insights from MRI perfusion imaging. Neurotherapeutics [Internet]. 2025;22(1):e00516. Available from: https://www.sciencedirect.com/science/article/pii/S1878747924002034
- Huang X, Hussain B, Chang J. Peripheral inflammation and blood– brain barrier disruption: effects and mechanisms. CNS Neurosci Ther [Internet]. 2021 Jan 1;27(1):36–47. Available from: https://doi.org/10.1111/cns.13569
- Rodríguez-Gómez JA, Kavanagh E, Engskog-Vlachos P, Engskog MKR, Herrera AJ, Espinosa-Oliva AM, et al. Microglia: Agents of the CNS Pro-Inflammatory Response. Vol. 9, Cells. 2020. p. 1717.
- Catană MG, Popențiu IA, Văleanu M, Roman-Filip C, Mihăilă RG. IL-1 Beta-A Biomarker for Ischemic Stroke Prognosis and Atherosclerotic Lesions of the Internal Carotid Artery. Medicina (Kaunas). 2023 Oct;59(10).
- Montaner J, Alvarez-Sabín J, Molina C, Anglés A, Abilleira S, Arenillas J, et al. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke. 2001 Aug;32(8):1759–66.
- Emmerich J, Chanpura A, Lu T, Baird A, Barone F, Gustafson D, et al. Blood-based MMP-9 for the early differentiation of acute ischemic stroke: a systematic review and meta-analysis. J stroke Cerebrovasc Dis Off J Natl Stroke Assoc. 2025 Nov;34(11):108454.
- Guo P, Li H, Zhang X, Liu Y, Xue S, Yong VW, et al. Matrix metalloproteinase-9 in hemorrhagic transformation after acute ischemic stroke (Review). Mol Med Rep. 2025 Aug;32(2).
- Iordache MP, Buliman A, Costea-Firan C, Gligore TCI, Cazacu IS, Stoian M, et al. Immunological and Inflammatory Biomarkers in the Prognosis, Prevention, and Treatment of Ischemic Stroke: A Review of a Decade of Advancement. Int J Mol Sci. 2025 Aug;26(16).
- Turner RJ, Sharp FR. Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke. Front Cell Neurosci [Internet]. 2016;Volume 10. Available from: https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2016.00056
- Pacinella G, Bona MM, Todaro F, Ciaccio AM, Daidone M, Tuttolomondo A. Tracing Inflammation in Ischemic Stroke: Biomarkers and Clinical Insight. Int J Mol Sci. 2025 Oct;26(19).
- Xiao L, Huang Y, Wu L, Zeng S, Qiu C, Li X, et al. The role of inflammation in Ischemic stroke: from biomarker to treatment. Front Immunol. 2025;16:1608353.
- Liang Y, Chen J, Chen Y, Tong Y, Li L, Xu Y, et al. Advances in the detection of biomarkers for ischemic stroke. Front Neurol. 2025;16:1488726.
- Matys P, Mirończuk A, Starosz A, Grubczak K, Kochanowicz J, Kułakowska A, et al. Expanding Role of Interleukin-1 Family Cytokines in Acute Ischemic Stroke. Int J Mol Sci. 2024 Sep;25(19).
- Tsai MM, Chen JL, Lee TH, Liu H, Shanmugam V, Hsieh HL. Brain Protective Effect of Resveratrol via Ameliorating Interleukin-1β-Induced MMP-9-Mediated Disruption of ZO-1 Arranged Integrity. Biomedicines. 2022 May;10(6).
- Zhu H, Hu S, Li Y, Sun Y, Xiong X, Hu X, et al. Interleukins and Ischemic Stroke. Front Immunol. 2022;13:828447.
- Yang C, Hawkins KE, Doré S, Candelario-Jalil E. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol Cell Physiol. 2019 Feb;316(2):C135–53.
- Wang H, Yiqiang Z, Cai J, Guo J. Immune-mediated blood-brain barrier disruption after ischemic stroke: mechanisms and therapeutic targets. Front Immunol. 2025;16:1716041.
- Cimmino G, Ragni M, Cirillo P, Petrillo G, Loffredo F, Chiariello M, et al. C-reactive protein induces expression of matrix metalloproteinase-9: a possible link between inflammation and plaque rupture. Int J Cardiol. 2013 Sep;168(2):981–6.
- Surjawan Y, As’ ad S, Ranakusuma TAS, Wijaya A. C-reactive protein and matrix metalloproteinase-9 are associated with outcome of ischemic stroke. Indones Biomed J. 2012;4(3):157–63.
- Sarafaniuk N, Klymenko M. PRODUCTION OF INTERLEUKINS 1β, 2, 4, 10 AND C-REACTIVE PROTEIN IN ISCHEMIC STROKE. Wiad Lek. 2022;75(3):598–604.
- Bonacina F, Pirillo A, Catapano AL, Norata GD. HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases. Cells. 2021 Apr;10(5).
- Thacker SG, Zarzour A, Chen Y, Alcicek MS, Freeman LA, Sviridov DO, et al. High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation. Immunology. 2016 Nov;149(3):306–19.
DOI: https://doi.org/10.62838/amsm-2026-0016 | Journal eISSN: 2668-7763 (formerly 2247-6113) | Journal ISSN: 2668-7755
Language: English
Page range: 220 - 226
Submitted on: Jan 28, 2026
Accepted on: May 25, 2026
Published online: Sep 30, 2026
Published in print: Sep 1, 2026
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Haider Adnan Rahman, Kadhem Muhammed Sabae, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.